GET DAILY SIGNALSGXPS vs IYK: Pure Consumer Staples Exposure or a More Diversified Approach?
Key Takeaways
- GXPS and IYK both target U.S. consumer staples, but they are structured differently: GXPS is an uncapped, pure-play index fund, while IYK applies capped weightings and blends in modest healthcare and materials exposure.
- Cost structure diverges sharply. GXPS carries a net expense ratio of about 0.15%, roughly half the level of IYK's approximate 0.38% fee, giving GXPS a structural cost advantage over time.
- Concentration differs meaningfully. GXPS holds roughly 31 names with its top 10 near 80% of assets, whereas IYK holds roughly 54–58 names with a top 10 closer to 66%, favoring IYK for broader diversification.
- Positioning tilts toward megacap leaders. GXPS is heavily weighted to Walmart and Costco, while IYK leans on Procter & Gamble, Coca-Cola, and Philip Morris International.
- Risk profiles vary. IYK is a mature, liquid, lower-beta fund with a long track record, while GXPS is a newer, smaller fund with less liquidity but purer sector exposure.
- Tickeron AI Verdict: On balance, Tickeron's AI favors GXPS for its lower cost and concentrated exposure to the sector's stronger momentum names, with the caveat of its smaller asset base.
Why This Comparison Matters Now
Consumer staples remain a core defensive holding for many portfolios, yet GXPS and IYK take noticeably different routes to the same sector. GXPS is a recently launched, uncapped pure-play tracking the MSCI USA Consumer Staples Index. IYK is a long-standing iShares fund that follows a capped benchmark and quietly mixes in some healthcare and materials exposure. The distinction is worth examining because concentration, fees, and liquidity can shape results across full market cycles.
A Closer Look at GXPS
GXPS seeks to track the MSCI USA Consumer Staples Index using an uncapped, free-float market-capitalization approach that lets the largest companies dominate. The fund employs representative sampling and is non-diversified. It holds roughly 31 securities, with the top 10 accounting for about 80% of assets. Leading positions include Walmart at roughly 16–17%, Costco Wholesale near 14%, Procter & Gamble around 11–12%, Coca-Cola about 10–11%, and Philip Morris International near 9–10%, followed by PepsiCo, Altria Group, Mondelez International, Target, and Colgate-Palmolive. Exposure is essentially 100% consumer staples, with a net expense ratio of 0.15% (0.25% gross). Launched in July 2025, the fund is still building assets, which affects trading liquidity.
A Closer Look at IYK
IYK tracks the Russell 1000 Consumer Staples RIC 22.5/45 Capped Index, which limits single-issuer weight to 22.5% and the top five names combined to 45%. The fund is non-diversified and has been around since June 2000. It holds roughly 54–58 securities, with the top 10 representing about 66% of assets. Top holdings include Procter & Gamble at around 13.5%, Coca-Cola near 12–13%, Philip Morris International about 11%, PepsiCo roughly 7–8%, plus CVS Health, McKesson, Altria Group, Mondelez International, Colgate-Palmolive, and Monster Beverage. Roughly 82–85% of exposure sits in consumer staples, with about 11% in healthcare and a small materials slice. Its expense ratio is approximately 0.38%.
The Broader Consumer Staples Backdrop
Both funds sit inside a sector often viewed as a defensive anchor when growth slows or volatility rises. Demand for everyday goods tends to hold up, though performance increasingly hinges on company execution. Recent drivers include share gains at grocery and warehouse retailers, pricing power amid cost pressures, and steady cash flows from tobacco and beverages. Offsetting factors include volume softness, currency effects, and regulatory attention on tobacco names. The sector’s low beta also makes it responsive to interest-rate expectations as income-focused investors shift allocations.
How the Two Funds Differ in Practice
Recent performance divergence has stemmed largely from weighting differences. GXPS’s uncapped structure has amplified exposure to Walmart and Costco, names that have seen steady traffic and market-share gains. IYK spreads weight more evenly and adds healthcare distributors such as McKesson and CVS Health. On volatility, IYK has shown a historical beta around 0.4–0.5 and a longer record of steadier behavior thanks to its caps and broader holdings. GXPS’s heavier concentration can magnify swings in both directions. On fees, GXPS’s 0.15% expense ratio offers a lasting edge versus IYK’s near-0.38% charge, a gap that compounds over longer periods. Liquidity still favors IYK given its larger size and longer history.
One Tool I Keep Returning To
When comparing sector ETFs like these, I often run quick scans with Tickeron’s AI Screener to check relative technical trends and industry positioning. It helps surface how concentration levels and cost differences line up across similar holdings without manual number crunching.
Tickeron AI Verdict
Balancing the observable factors, Tickeron’s AI leans toward GXPS at present. Its lower expense ratio, pure staples focus, and uncapped exposure to stronger momentum names create a structural and tactical edge. IYK’s greater diversification, lower beta, and superior liquidity remain meaningful advantages, yet they are partly offset by the higher fee and the healthcare dilution. The assessment is probabilistic: investors prioritizing stability and trading ease may still prefer IYK, while those seeking concentrated, cost-efficient sector exposure may find GXPS more suitable.
Using Tickeron’s AI Screener for Deeper ETF Work
In my research process I occasionally cross-check holdings and momentum signals with Tickeron’s AI Screener. The tool lets me apply filters for industry, technical patterns, and performance metrics across thousands of names, which helps clarify how GXPS and IYK stack up against peers without spending hours on spreadsheets. It has become a regular part of evaluating relative positioning before making allocation decisions.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
IYK's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for IYK turned positive on October 07, 2026. Looking at past instances where IYK's MACD turned positive, the stock continued to rise in 38 of 44 cases over the following month. The odds of a continued upward trend are 86%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on IYK as a result. In 70 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 80%.
IYK moved above its 50-day moving average on October 08, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for IYK crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 72%.
Following a +2.27% 3-day Advance, the price is estimated to grow further. Considering data from situations where IYK advanced for three days, in 265 of 336 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
The Aroon Indicator entered an Uptrend today. In 232 of 299 cases where IYK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 78%.
Bearish Trend Analysis
The 10-day RSI Indicator for IYK moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In 30 of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at 79%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 43 of 61 cases where IYK's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 70%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IYK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.
IYK broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Category ConsumerStaples